Reshape Lifesciences Inc. has entered into an Agreement and Plan of Merger with Vyome Therapeutics, Inc. and Raider Lifesciences Inc., and an Asset Purchase Agreement with Ninjour Health International Limited. They have also entered into agreements for a Concurrent Financing. The Merger Agreement includes a reduction in the liquidation preference of the Series C Preferred Stock. The Merger is subject to customary closing conditions.